EnWave Corporation Retains The Equity Group to Provide Investor Relations Services


VANCOUVER, BC--(Marketwired - February 24, 2016) - EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company") has retained The Equity Group Inc. of New York, NY to provide investor relations services throughout the capital markets.

EnWave has expanded its portfolio of royalty streams through the commercialization of its patented Radiant Energy Vacuum (REV™) dehydration technology with partner companies in the food and pharmaceutical industries. Going forward, the Company will maintain its aggressive focus on continuing to expand its royalty partner pipeline through its proactive business development strategy. Commercial interest in EnWave's REV™ technology continues to build. This positive momentum has led EnWave to engage The Equity Group in order to assist the Company in conveying an exciting and evolving investment case to investors and analysts globally.

Terms call for EnWave to compensate The Equity Group Inc. on a month to month basis, at the rate of US $5,000 per month, commencing March, 2016 and subject to termination upon 30 days-notice by either party.

The Equity Group Inc., which was founded in 1974, provides a full spectrum of investor and financial public relations service. For more information, please visit www.theequitygroup.com.

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV™) dehydration technology. EnWave aims to sign royalty-bearing commercial licenses with leading food and pharmaceutical companies for the use of its revolutionary technology. To date, the Company has signed fifteen royalty-bearing commercial licenses with various companies, thereby opening up eight distinct market sectors for commercialization. In addition to these fifteen licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products within the United States of America under the Moon Cheese® brand.

EnWave is introducing REV™ technology as a new dehydration standard in the food and biological material sectors, with benefits including, but not limited to, a faster and cheaper method compared to freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms:

1. nutraREV® (food industry applications): designed for quick, low-cost dehydration of fruits, vegetables, herbs, dairy products, meats and seafood, with benefits including improved nutritional content, appearance, flavor and texture relative to conventional methods.

2. quantaREV® (food industry applications): designed for high-volume, low-temperature dehydration of solids, liquids, granular or encapsulated products.

3. powderREV® (pharmaceutical applications): designed as a high-speed, lower-energy, continuous alternative to freeze drying for bulk dehydration of temperature-sensitive biomaterials (bacteria, cell-free extracts, enzymes, probiotics, food cultures, etc.).

In addition, EnWave is currently developing a new commercial REV™ platform:

1. freezeREV® (pharmaceutical applications): a multi-vial prototype technology designed to act as an accelerated freeze dryer to produce room-temperature stable biopharmaceuticals and reagents.

More information about EnWave is available at www.enwave.net

 EnWave Corporation

Dr. Tim Durance

President & CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:

For further information:

John Budreski
Executive Chairman
EnWave Corporation
+1 (416) 930-0914
E-mail: jbudreski@enwave.net

Brent Charleton
Senior Vice President, Business Development
+1 (778) 378-9616
E-mail: bcharleton@enwave.net
 
Jeremy Hellman
Senior Associate
The Equity Group
+1 (212) 836-9626
E-mail: jhellman@equityny.com